Form 4: ANI Pharmaceuticals Executive Ori Gutwerg Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Ori Gutwerg, SVP of Generics at ANI Pharmaceuticals, reports acquisition and disposal of common stock due to vesting of restricted stock and performance stock units, as well as shares withheld for tax purposes.
Summary
- Ori Gutwerg, SVP of Generics at ANI Pharmaceuticals, filed a Form 4 detailing changes in beneficial ownership.
- On February 12, 2025, Gutwerg acquired 15,668 shares of common stock through a restricted stock award vesting in equal annual installments over four years.
- Additionally, 10,444 shares were acquired as performance stock units, vesting based on performance targets and continued service.
- On February 14 and 15, 2025, 1,426 and 1,167 shares, respectively, were disposed of at $58.92 per share to cover tax obligations related to vesting restricted stock.
- Following these transactions, Gutwerg beneficially owns 100,746 shares of ANI Pharmaceuticals common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in the pharmaceutical industry.
Stakeholder Impact
- The filing provides transparency to shareholders regarding executive compensation and stock ownership.
Key Dates
| Date | Description |
|---|---|
| 02/12/2025 | Acquisition of common stock through restricted stock award and performance stock units. |
| 02/14/2025 | Disposal of shares for tax purposes related to vesting restricted stock. |
| 02/15/2025 | Disposal of shares for tax purposes related to vesting restricted stock. |
| 02/18/2025 | Date of signature on the Form 4 filing. |
Keywords
Form 4, Beneficial Ownership, ANI Pharmaceuticals, Gutwerg, Stock Options, Restricted Stock, Performance Stock Units, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.